Attorney General Abbott Recovers $39.75 Million for State of Texas, U.S. Medicaid Program
AUSTIN-Texas Attorney General Greg Abbott has resolved an enforcement action against Ranbaxy, a generic drug manufacturer. The agreement resolves the State's lawsuit under the Texas Medicaid Fraud Prevention Act ("TMFPA") against Ranbaxy Pharmaceuticals, Inc., Ranbaxy Laboratories, Inc., Ranbaxy USA, Inc. and Ranbaxy, Inc. for fraudulently reporting inflated drug prices to the Medicaid program.
- Date:October 16, 2014
- Agency:Texas Attorney General
- State Enforcement Agencies